Mol. Cells
Published online September 13, 2023
© The Korean Society for Molecular and Cellular Biology
Correspondence to : scbae@chungbuk.ac.kr(SCB); jeongwon@chungbuk.ac.kr(JWL)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
The Hippo kinase cascade functions as a central hub that relays input from the “outside world” of the cell and translates it into specific cellular responses by regulating the activity of Yes-associated protein 1 (YAP1). How Hippo translates input from the extracellular signals into specific intracellular responses remains unclear. Here, we show that transforming growth factor β (TGFβ)-activated TAK1 activates LATS1/2, which then phosphorylates YAP1. Phosphorylated YAP1 (p-YAP1) associates with RUNX3, but not with TEAD4, to form a TGFβ-stimulated restriction (R)-point-associated complex which activates target chromatin loci in the nucleus. Soon after, p-YAP1 is exported to the cytoplasm. Attenuation of TGFβ signaling results in re-localization of unphosphorylated YAP1 to the nucleus, where it forms a YAP1/TEAD4/SMAD3/AP1/p300 complex. The TGFβ-stimulated spatiotemporal dynamics of YAP1 are abrogated in many cancer cells. These results identify a new pathway that integrates TGFβ signals and the Hippo pathway (TGFβ→TAK1→LATS1/2→YAP1 cascade) with a novel dynamic nuclear role for p-YAP1.
Keywords LATS1/2, restriction point, RUNX3, TAK1, TGFβ, YAP1
Mol. Cells
Published online September 13, 2023
Copyright © The Korean Society for Molecular and Cellular Biology.
Min-Kyu Kim1,6, Sang-Hyun Han1,6, Tae-Geun Park1, Soo-Hyun Song1, Ja-Youl Lee1, You-Soub Lee1, Seo-Yeong Yoo1, Xin-Zi Chi1, Eung-Gook Kim2, Ju-Won Jang3, Dae Sik Lim4, Andre J. van Wijnen5, Jung-Won Lee1,* , and Suk-Chul Bae1,*
1Department of Biochemistry, College of Medicine and Institute for Tumour Research, Chungbuk National University, Cheongju 28644, Korea, 2Department of Biochemistry, College of Medicine and Medical Research Center, Chungbuk National University, Cheongju 28644, Korea, 3Department of Biomedical Science, Cheongju University, Cheongju 28503, Korea, 4Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea, 5Department of Biochemistry, University of Vermont, Burlington, VT 05405, USA, 6These authors contributed equally to this work.
Correspondence to:scbae@chungbuk.ac.kr(SCB); jeongwon@chungbuk.ac.kr(JWL)
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
The Hippo kinase cascade functions as a central hub that relays input from the “outside world” of the cell and translates it into specific cellular responses by regulating the activity of Yes-associated protein 1 (YAP1). How Hippo translates input from the extracellular signals into specific intracellular responses remains unclear. Here, we show that transforming growth factor β (TGFβ)-activated TAK1 activates LATS1/2, which then phosphorylates YAP1. Phosphorylated YAP1 (p-YAP1) associates with RUNX3, but not with TEAD4, to form a TGFβ-stimulated restriction (R)-point-associated complex which activates target chromatin loci in the nucleus. Soon after, p-YAP1 is exported to the cytoplasm. Attenuation of TGFβ signaling results in re-localization of unphosphorylated YAP1 to the nucleus, where it forms a YAP1/TEAD4/SMAD3/AP1/p300 complex. The TGFβ-stimulated spatiotemporal dynamics of YAP1 are abrogated in many cancer cells. These results identify a new pathway that integrates TGFβ signals and the Hippo pathway (TGFβ→TAK1→LATS1/2→YAP1 cascade) with a novel dynamic nuclear role for p-YAP1.
Keywords: LATS1/2, restriction point, RUNX3, TAK1, TGFβ, YAP1
Ki-Hong Jang, Chloe R. Heras, and Gina Lee
Mol. Cells 2022; 45(7): 435-443 https://doi.org/10.14348/molcells.2022.0017Kerri Sweeney, Ewan R. Cameron, and Karen Blyth
Mol. Cells 2020; 43(2): 188-197 https://doi.org/10.14348/molcells.2019.0310Jung-Won Lee and Suk-Chul Bae
Mol. Cells 2020; 43(2): 182-187 https://doi.org/10.14348/molcells.2019.0319